Onuma Y - Search Results

1

Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial.

Cavalcante R, Onuma Y, Sotomi Y, Collet C, Thomsen B, Rogers C, Zeng Y, Tenekecioglu E, Asano T, Miyasaki Y, Abdelghani M, Morel MA, Serruys PW. Cavalcante R, et al. Among authors: onuma y. EuroIntervention. 2017 Mar 20;12(16):2001-2008. doi: 10.4244/EIJ-D-16-00612. EuroIntervention. 2017. PMID: 27973335 Free article. Clinical Trial.

2

Revascularization in the high-risk patient: multivessel disease.

Onuma Y, Daemen J, Kukreja N, Serruys P. Onuma Y, et al. Minerva Cardioangiol. 2007 Oct;55(5):579-92. Minerva Cardioangiol. 2007. PMID: 17912164 Review.

3

The future of drug-eluting stents.

Kukreja N, Onuma Y, Daemen J, Serruys PW. Kukreja N, et al. Among authors: onuma y. Pharmacol Res. 2008 Mar;57(3):171-80. doi: 10.1016/j.phrs.2008.01.012. Epub 2008 Feb 2. Pharmacol Res. 2008. PMID: 18339557 Review.

4

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.

Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. Ormiston JA, et al. Among authors: onuma y. Lancet. 2008 Mar 15;371(9616):899-907. doi: 10.1016/S0140-6736(08)60415-8. Lancet. 2008. PMID: 18342684 Clinical Trial.

5

Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry.

Daemen J, Kukreja N, van Twisk PH, Onuma Y, de Jaegere PP, van Domburg R, Serruys PW. Daemen J, et al. Among authors: onuma y. Am J Cardiol. 2008 Apr 15;101(8):1105-11. doi: 10.1016/j.amjcard.2007.11.074. Epub 2008 Feb 20. Am J Cardiol. 2008. PMID: 18394442

6

Coronary plaque composition as assessed by greyscale intravascular ultrasound and radiofrequency spectral data analysis.

Gonzalo N, García-García HM, Ligthart J, Rodriguez-Granillo G, Meliga E, Onuma Y, Schuurbiers JC, Bruining N, Serruys PW. Gonzalo N, et al. Among authors: onuma y. Int J Cardiovasc Imaging. 2008 Dec;24(8):811-8. doi: 10.1007/s10554-008-9324-2. Epub 2008 Jun 12. Int J Cardiovasc Imaging. 2008. PMID: 18548332

7

Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients.

Kukreja N, Onuma Y, Garcia-Garcia HM, Daemen J, van Domburg R, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000-5). Kukreja N, et al. Among authors: onuma y. Am J Cardiol. 2009 Jan 15;103(2):203-11. doi: 10.1016/j.amjcard.2008.08.068. Epub 2008 Nov 19. Am J Cardiol. 2009. PMID: 19121437

8

Guidelines for reporting mortality and morbidity after cardiac valve interventions--need for a reappraisal?

Piazza N, Onuma Y, de Jaegere P, Serruys PW. Piazza N, et al. Among authors: onuma y. Ann Thorac Surg. 2009 Feb;87(2):357-8; discussion 359-60. doi: 10.1016/j.athoracsur.2008.11.054. Ann Thorac Surg. 2009. PMID: 19161735 No abstract available.

9

The paradigm of endothelium and stent thrombosis in DES.

Onuma Y, van Beusekom HM, Sorop O, van der Giessen WJ. Onuma Y, et al. EuroIntervention. 2008 Aug;4 Suppl C:C17-21. EuroIntervention. 2008. PMID: 19202686

10

Advances in stent drug delivery: the future is in bioabsorbable stents.

Wykrzykowska JJ, Onuma Y, Serruys PW. Wykrzykowska JJ, et al. Among authors: onuma y. Expert Opin Drug Deliv. 2009 Feb;6(2):113-26. doi: 10.1517/17425240802668495. Expert Opin Drug Deliv. 2009. PMID: 19239384 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

846 results

Search Page

Filters